Cataract & Refractive

The Malyugin Ring 2.0 simplifies challenging cases of small pupils with zonulopathy by both stabilising the capsular bag and dilating the pupil.

Corneal aberrations may occur more frequently than is generally appreciated, and they affect the visual outcomes following cataract surgery. Small-aperture optics provide a solution for a large category of patients who are otherwise not well served by complex IOLs.

The GMOPC was established in February 2020 at an inaugural meeting in Los Angeles, California, as an investigator-initiated clinical research study, with Heidelberg Engineering as an industry partner.

Dr Lisa Nijm discusses how utilising a dexamethasone intracanalicular insert after cataract surgery saves time for practices.

Laser vision advancements have made safe, reliable and stable procedures a reality.

Drug delivery solutions to manage pain after cataract surgery improves adherence.

Giving due consideration to preoperative marking and the surgical technique in toric IOL implantation, as well as being diligent about reviewing postoperative results, can improve patient outcomes whilst minimising the chance of errors.

The VIVID study focuses on three novel topical ophthalmic formulations under investigation for the treatment of presbyopia.

This three-part feature discusses tips for success when getting started with toric IOLs. Part 2 tackles calculating toric IOL sphere and cylinder power; though it can seem daunting when treating astigmatism, the process can be simplified with a few key considerations.

Dr Mohamed Abou Shousha discusses Heru’s wearable AI-powered diagnostic devices at AAO 2021.

Patients desire spectacle independence at all distances. Early experience with a recently launched IOL suggests that it can satisfy their demands for extended depth of vision.

Dr Cathleen McCabe describes how VUITY, the first and only FDA-approved eye drop to treat age-related blurry near vision, provides opportunities for patients looking for spectacle independence.

Dr Timothy G. Murray discusses the 5-year followup data from a large, consecutive case series of combined anterior and posterior segment surgery and the benefits of a single procedure for the recovery of vision and decreased risk.

Allergan developed VUITY, which it noted is the first and only FDA-approved eye drop to treat presbyopia.

Cataract surgery on very small children presents some unique challenges that can be overcome with the use of a femtosecond laser.

This three-part feature discusses tips for success when getting started with toric IOLs. Part 1 looks at patient selection and optimising biometry; Part 2 examines IOL calculation; and Part 3 looks at the perioperative period and postoperative troubleshooting.

Ophthalmologists gather to discuss artificial intelligence and the issue of false negatives, practice for surgeons and Best of the Best at the European Society of Cataract and Refractive Surgeons congress.

Talk of lens selection and patient satisfaction dominated discussion during the Advanced IOLs Symposium; cost vs. benefit analysis emerges as a theme throughout the congress.

There is no significant difference between IOL replacement and rescue in terms of postoperative visual and surgical outcomes for eyes undergoing secondary IOL scleral fixation.

Evidence from clinical trials and real-world situations demonstrates the effectiveness and convenience of intraocular drugs to control postoperative inflammation.

A new IOL combines the advantages of diffractive multifocal and extended-depth-of-focus lenses, providing a natural range of vision.

A recent prospective study analysed the relationship between corneo-scleral geometry and the axial length of the eye to develop preliminary prediction models of the axial length of the eye based on clinical data.

The 39th Congress of the European Society for Cataract and Refractive Surgery (ESCRS) will meet at RAI Congress Centre in Amsterdam, the Netherlands, from 8–11 October 2021. The Congress will also be held virtually, making the chance to participate in some capacity a reality for all.

Cataract surgeons and nurses would support having re-usable equipment and supplies to reduce operating theatre waste and carbon footprint.